PDB Short entry for 2PXA HEADER TRANSFERASE 14-MAY-07 2PXA TITLE CRYSTAL STRUCTURE OF THE MURRAY VALLEY ENCEPHALITIS VIRUS NS5 2'-O TITLE 2 METHYLTRANSFERASE DOMAIN IN COMPLEX WITH SAH AND GTPG COMPND MOL_ID: 1; COMPND 2 MOLECULE: GENOME POLYPROTEIN [CONTAINS: CAPSID PROTEIN C (CORE COMPND 3 PROTEIN); ENVELOPE PROTEIN M (MATRIX PROTEIN); MAJOR ENVELOPE PROTEIN COMPND 4 E; NON-STRUCTURAL PROTEIN 1 (NS1); NON-STRUCTURAL PROTEIN 2A (NS2A); COMPND 5 FLAVIVIRIN PROTEASE NS2B REGULATORY SUBUNIT; FLAVIVIRIN PROTEASE NS3 COMPND 6 CATALYTIC SUBUNIT; NON-STRUCTURAL PROTEIN 4A (NS4A); NON-STRUCTURAL COMPND 7 PROTEIN 4B (NS4B); RNA-DIRECTED RNA POLYMERASE (EC 2.7.7.48) (NS5)]; COMPND 8 CHAIN: A, B; COMPND 9 FRAGMENT: NS5 2'-O METHYLTRANSFERASE DOMAIN: RESIDUES 2530-2798; COMPND 10 EC: 2.7.7.48; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MURRAY VALLEY ENCEPHALITIS VIRUS (STRAIN MVE-1- SOURCE 3 51); SOURCE 4 ORGANISM_TAXID: 301478; SOURCE 5 STRAIN: MVE-1-51, MVEV; SOURCE 6 GENE: NS5; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: ROSETTA(DE3)PLYSS; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: OPPF2936 KEYWDS MURRAY VALLEY ENCEPHALITIS VIRUS, METHYLTRANSFERASE, SAH, GTPG, GTP, KEYWDS 2 STRUCTURAL GENOMICS, OXFORD PROTEIN PRODUCTION FACILITY, OPPF, KEYWDS 3 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR R.ASSENBERG,J.REN,A.VERMA,T.S.WALTER,D.ALDERTON,R.J.HURRELBRINK, AUTHOR 2 S.D.FULLER,R.J.OWENS,D.I.STUART,J.M.GRIMES,OXFORD PROTEIN PRODUCTION AUTHOR 3 FACILITY (OPPF) REVDAT 5 30-AUG-23 2PXA 1 REMARK REVDAT 4 13-JUL-11 2PXA 1 VERSN REVDAT 3 24-FEB-09 2PXA 1 VERSN REVDAT 2 24-JUL-07 2PXA 1 JRNL REVDAT 1 29-MAY-07 2PXA 0 JRNL AUTH R.ASSENBERG,J.REN,A.VERMA,T.S.WALTER,D.ALDERTON, JRNL AUTH 2 R.J.HURRELBRINK,S.D.FULLER,S.BRESSANELLI,R.J.OWENS, JRNL AUTH 3 D.I.STUART,J.M.GRIMES JRNL TITL CRYSTAL STRUCTURE OF THE MURRAY VALLEY ENCEPHALITIS VIRUS JRNL TITL 2 NS5 METHYLTRANSFERASE DOMAIN IN COMPLEX WITH CAP ANALOGUES. JRNL REF J.GEN.VIROL. V. 88 2228 2007 JRNL REFN ISSN 0022-1317 JRNL PMID 17622627 JRNL DOI 10.1099/VIR.0.82757-0 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 23377 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1222 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1680 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.99 REMARK 3 BIN R VALUE (WORKING SET) : 0.2630 REMARK 3 BIN FREE R VALUE SET COUNT : 81 REMARK 3 BIN FREE R VALUE : 0.3750 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4164 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 116 REMARK 3 SOLVENT ATOMS : 244 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.26 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.48000 REMARK 3 B22 (A**2) : -0.38000 REMARK 3 B33 (A**2) : -0.10000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.407 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.253 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.204 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 15.970 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.945 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.916 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4374 ; 0.009 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 3122 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5902 ; 1.246 ; 1.993 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7542 ; 0.813 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 522 ; 4.912 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 192 ;34.493 ;22.708 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 792 ;14.704 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 44 ;14.445 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 614 ; 0.066 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4750 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 898 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 869 ; 0.196 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 3271 ; 0.188 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2058 ; 0.176 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 2288 ; 0.083 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 213 ; 0.138 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 18 ; 0.123 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 43 ; 0.255 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 9 ; 0.168 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3397 ; 4.299 ; 4.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1082 ; 1.209 ; 4.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4166 ; 4.975 ; 6.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2166 ; 6.499 ; 6.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1736 ; 8.719 ;10.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 6 A 267 6 REMARK 3 1 B 6 B 267 6 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 1532 ; 0.20 ; 0.50 REMARK 3 LOOSE POSITIONAL 1 A (A): 2090 ; 0.65 ; 5.00 REMARK 3 MEDIUM THERMAL 1 A (A**2): 1532 ; 3.16 ; 20.00 REMARK 3 LOOSE THERMAL 1 A (A**2): 2090 ; 3.82 ; 30.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 6 A 267 REMARK 3 ORIGIN FOR THE GROUP (A): -0.5940 -21.6000 28.4150 REMARK 3 T TENSOR REMARK 3 T11: -0.1262 T22: -0.1715 REMARK 3 T33: -0.1249 T12: -0.0335 REMARK 3 T13: -0.0027 T23: 0.0266 REMARK 3 L TENSOR REMARK 3 L11: 3.3126 L22: 2.4582 REMARK 3 L33: 1.1144 L12: -1.1386 REMARK 3 L13: -0.2940 L23: -0.0078 REMARK 3 S TENSOR REMARK 3 S11: -0.0245 S12: 0.2587 S13: -0.2103 REMARK 3 S21: -0.0311 S22: 0.0043 S23: 0.2177 REMARK 3 S31: 0.0641 S32: -0.0184 S33: 0.0202 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 6 B 267 REMARK 3 ORIGIN FOR THE GROUP (A): 1.0780 -18.8410 -6.9690 REMARK 3 T TENSOR REMARK 3 T11: -0.1881 T22: -0.1118 REMARK 3 T33: -0.1472 T12: -0.0091 REMARK 3 T13: 0.0454 T23: 0.0020 REMARK 3 L TENSOR REMARK 3 L11: 1.1682 L22: 3.2509 REMARK 3 L33: 1.2019 L12: -0.3573 REMARK 3 L13: -0.1811 L23: -0.0541 REMARK 3 S TENSOR REMARK 3 S11: -0.0225 S12: -0.0194 S13: -0.0303 REMARK 3 S21: 0.0674 S22: 0.0212 S23: -0.1177 REMARK 3 S31: 0.0358 S32: 0.0274 S33: 0.0012 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. CNS PROGRAM HAS ALSO BEEN USED IN REFINEMENT REMARK 4 REMARK 4 2PXA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-MAY-07. REMARK 100 THE DEPOSITION ID IS D_1000042881. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-MAR-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.93400 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24920 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -1.500 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 13.80 REMARK 200 R MERGE (I) : 0.09100 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 32.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.40 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 9.70 REMARK 200 R MERGE FOR SHELL (I) : 0.66200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2PX2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.23 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M AMMONIUM ACETATE, 0.1 M SODIUM REMARK 280 ACETATE PH 4.6, 30 % W/V PEG 4000, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 39.71150 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 42.40700 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.14000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 42.40700 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 39.71150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 40.14000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1 REMARK 465 ARG A 2 REMARK 465 ALA A 3 REMARK 465 GLY A 4 REMARK 465 GLY A 5 REMARK 465 GLY A 268 REMARK 465 LYS A 269 REMARK 465 GLY B 1 REMARK 465 ARG B 2 REMARK 465 ALA B 3 REMARK 465 GLY B 4 REMARK 465 GLY B 5 REMARK 465 GLY B 268 REMARK 465 LYS B 269 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 44 -60.59 -100.69 REMARK 500 ARG B 69 24.78 48.98 REMARK 500 GLN B 117 50.40 -117.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 AUTHORS STATE THAT THE PROTEIN WAS COCRYSTALLIZED WITH GTPG REMARK 600 [P1-(GUANOSINE-5')-P3-(GUANOSINE-5')-TRIPHOSPHATE], BUT REMARK 600 THERE IS NO ELECTRON DENSITY FOR THE SECOND GUANOSINE GROUP. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GTP A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GTP B 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAH B 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAH A 500 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2PX2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MURRAY VALLEY ENCEPHALITIS VIRUS NS5 2'-O REMARK 900 METHYLTRANSFERASE DOMAIN IN COMPLEX WITH SAH (MONOCLINIC FORM 1) REMARK 900 RELATED ID: 2PX4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MURRAY VALLEY ENCEPHALITIS VIRUS NS5 2'-O REMARK 900 METHYLTRANSFERASE DOMAIN IN COMPLEX WITH SAH (MONOCLINIC FORM 2) REMARK 900 RELATED ID: 2PX5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MURRAY VALLEY ENCEPHALITIS VIRUS NS5 2'-O REMARK 900 METHYLTRANSFERASE DOMAIN IN COMPLEX WITH SAH (ORTHORHOMBIC CRYSTAL REMARK 900 FORM) REMARK 900 RELATED ID: 2PX8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MURRAY VALLEY ENCEPHALITIS VIRUS NS5 2'-O REMARK 900 METHYLTRANSFERASE DOMAIN IN COMPLEX WITH SAH AND 7M-GTP REMARK 900 RELATED ID: 2PXC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MURRAY VALLEY ENCEPHALITIS VIRUS NS5 2'-O REMARK 900 METHYLTRANSFERASE DOMAIN IN COMPLEX WITH SAM AND GTPA DBREF 2PXA A 1 269 UNP P05769 POLG_MVEV5 2530 2798 DBREF 2PXA B 1 269 UNP P05769 POLG_MVEV5 2530 2798 SEQRES 1 A 269 GLY ARG ALA GLY GLY ARG THR LEU GLY GLU GLN TRP LYS SEQRES 2 A 269 GLU LYS LEU ASN ALA MET GLY LYS GLU GLU PHE PHE SER SEQRES 3 A 269 TYR ARG LYS GLU ALA ILE LEU GLU VAL ASP ARG THR GLU SEQRES 4 A 269 ALA ARG ARG ALA ARG ARG GLU GLY ASN LYS VAL GLY GLY SEQRES 5 A 269 HIS PRO VAL SER ARG GLY THR ALA LYS LEU ARG TRP LEU SEQRES 6 A 269 VAL GLU ARG ARG PHE VAL GLN PRO ILE GLY LYS VAL VAL SEQRES 7 A 269 ASP LEU GLY CYS GLY ARG GLY GLY TRP SER TYR TYR ALA SEQRES 8 A 269 ALA THR MET LYS ASN VAL GLN GLU VAL ARG GLY TYR THR SEQRES 9 A 269 LYS GLY GLY PRO GLY HIS GLU GLU PRO MET LEU MET GLN SEQRES 10 A 269 SER TYR GLY TRP ASN ILE VAL THR MET LYS SER GLY VAL SEQRES 11 A 269 ASP VAL PHE TYR LYS PRO SER GLU ILE SER ASP THR LEU SEQRES 12 A 269 LEU CYS ASP ILE GLY GLU SER SER PRO SER ALA GLU ILE SEQRES 13 A 269 GLU GLU GLN ARG THR LEU ARG ILE LEU GLU MET VAL SER SEQRES 14 A 269 ASP TRP LEU SER ARG GLY PRO LYS GLU PHE CYS ILE LYS SEQRES 15 A 269 ILE LEU CYS PRO TYR MET PRO LYS VAL ILE GLU LYS LEU SEQRES 16 A 269 GLU SER LEU GLN ARG ARG PHE GLY GLY GLY LEU VAL ARG SEQRES 17 A 269 VAL PRO LEU SER ARG ASN SER ASN HIS GLU MET TYR TRP SEQRES 18 A 269 VAL SER GLY ALA SER GLY ASN ILE VAL HIS ALA VAL ASN SEQRES 19 A 269 MET THR SER GLN VAL LEU ILE GLY ARG MET ASP LYS LYS SEQRES 20 A 269 ILE TRP LYS GLY PRO LYS TYR GLU GLU ASP VAL ASN LEU SEQRES 21 A 269 GLY SER GLY THR ARG ALA VAL GLY LYS SEQRES 1 B 269 GLY ARG ALA GLY GLY ARG THR LEU GLY GLU GLN TRP LYS SEQRES 2 B 269 GLU LYS LEU ASN ALA MET GLY LYS GLU GLU PHE PHE SER SEQRES 3 B 269 TYR ARG LYS GLU ALA ILE LEU GLU VAL ASP ARG THR GLU SEQRES 4 B 269 ALA ARG ARG ALA ARG ARG GLU GLY ASN LYS VAL GLY GLY SEQRES 5 B 269 HIS PRO VAL SER ARG GLY THR ALA LYS LEU ARG TRP LEU SEQRES 6 B 269 VAL GLU ARG ARG PHE VAL GLN PRO ILE GLY LYS VAL VAL SEQRES 7 B 269 ASP LEU GLY CYS GLY ARG GLY GLY TRP SER TYR TYR ALA SEQRES 8 B 269 ALA THR MET LYS ASN VAL GLN GLU VAL ARG GLY TYR THR SEQRES 9 B 269 LYS GLY GLY PRO GLY HIS GLU GLU PRO MET LEU MET GLN SEQRES 10 B 269 SER TYR GLY TRP ASN ILE VAL THR MET LYS SER GLY VAL SEQRES 11 B 269 ASP VAL PHE TYR LYS PRO SER GLU ILE SER ASP THR LEU SEQRES 12 B 269 LEU CYS ASP ILE GLY GLU SER SER PRO SER ALA GLU ILE SEQRES 13 B 269 GLU GLU GLN ARG THR LEU ARG ILE LEU GLU MET VAL SER SEQRES 14 B 269 ASP TRP LEU SER ARG GLY PRO LYS GLU PHE CYS ILE LYS SEQRES 15 B 269 ILE LEU CYS PRO TYR MET PRO LYS VAL ILE GLU LYS LEU SEQRES 16 B 269 GLU SER LEU GLN ARG ARG PHE GLY GLY GLY LEU VAL ARG SEQRES 17 B 269 VAL PRO LEU SER ARG ASN SER ASN HIS GLU MET TYR TRP SEQRES 18 B 269 VAL SER GLY ALA SER GLY ASN ILE VAL HIS ALA VAL ASN SEQRES 19 B 269 MET THR SER GLN VAL LEU ILE GLY ARG MET ASP LYS LYS SEQRES 20 B 269 ILE TRP LYS GLY PRO LYS TYR GLU GLU ASP VAL ASN LEU SEQRES 21 B 269 GLY SER GLY THR ARG ALA VAL GLY LYS HET GTP A 401 32 HET SAH A 500 26 HET GTP B 403 32 HET SAH B 500 26 HETNAM GTP GUANOSINE-5'-TRIPHOSPHATE HETNAM SAH S-ADENOSYL-L-HOMOCYSTEINE FORMUL 3 GTP 2(C10 H16 N5 O14 P3) FORMUL 4 SAH 2(C14 H20 N6 O5 S) FORMUL 7 HOH *244(H2 O) HELIX 1 1 THR A 7 MET A 19 1 13 HELIX 2 2 GLY A 20 LYS A 29 1 10 HELIX 3 3 ARG A 37 ARG A 42 1 6 HELIX 4 4 ARG A 57 ARG A 68 1 12 HELIX 5 5 GLY A 85 THR A 93 1 9 HELIX 6 6 GLY A 120 ASN A 122 5 3 HELIX 7 7 ASP A 131 LYS A 135 5 5 HELIX 8 8 SER A 153 SER A 173 1 21 HELIX 9 9 MET A 188 GLY A 203 1 16 HELIX 10 10 ASN A 228 ARG A 243 1 16 HELIX 11 11 THR B 7 MET B 19 1 13 HELIX 12 12 GLY B 20 LYS B 29 1 10 HELIX 13 13 ARG B 37 GLU B 46 1 10 HELIX 14 14 ARG B 57 ARG B 68 1 12 HELIX 15 15 GLY B 85 ALA B 92 1 8 HELIX 16 16 GLY B 120 ASN B 122 5 3 HELIX 17 17 ASP B 131 LYS B 135 5 5 HELIX 18 18 SER B 153 SER B 173 1 21 HELIX 19 19 MET B 188 GLY B 203 1 16 HELIX 20 20 ASN B 228 ARG B 243 1 16 SHEET 1 A 2 LEU A 33 VAL A 35 0 SHEET 2 A 2 LYS A 253 GLU A 255 1 O GLU A 255 N GLU A 34 SHEET 1 B 7 VAL A 124 LYS A 127 0 SHEET 2 B 7 VAL A 97 TYR A 103 1 N GLY A 102 O THR A 125 SHEET 3 B 7 GLY A 75 LEU A 80 1 N VAL A 77 O ARG A 101 SHEET 4 B 7 THR A 142 CYS A 145 1 O LEU A 144 N LEU A 80 SHEET 5 B 7 GLU A 178 ILE A 183 1 O LYS A 182 N CYS A 145 SHEET 6 B 7 MET A 219 VAL A 222 -1 O MET A 219 N ILE A 183 SHEET 7 B 7 GLY A 205 VAL A 207 -1 N GLY A 205 O VAL A 222 SHEET 1 C 2 LEU B 33 VAL B 35 0 SHEET 2 C 2 LYS B 253 GLU B 255 1 O LYS B 253 N GLU B 34 SHEET 1 D 7 VAL B 124 LYS B 127 0 SHEET 2 D 7 VAL B 97 TYR B 103 1 N GLY B 102 O LYS B 127 SHEET 3 D 7 GLY B 75 LEU B 80 1 N VAL B 77 O GLU B 99 SHEET 4 D 7 THR B 142 CYS B 145 1 O LEU B 144 N LEU B 80 SHEET 5 D 7 GLU B 178 ILE B 183 1 O LYS B 182 N CYS B 145 SHEET 6 D 7 MET B 219 VAL B 222 -1 O MET B 219 N ILE B 183 SHEET 7 D 7 GLY B 205 VAL B 207 -1 N VAL B 207 O TYR B 220 SITE 1 AC1 14 LYS A 13 LEU A 16 ASN A 17 MET A 19 SITE 2 AC1 14 PHE A 24 ARG A 28 SER A 150 SER A 151 SITE 3 AC1 14 PRO A 152 SER A 215 HOH A 444 HOH A 560 SITE 4 AC1 14 HOH A 619 ARG B 42 SITE 1 AC2 13 LYS B 13 LEU B 16 ASN B 17 MET B 19 SITE 2 AC2 13 PHE B 24 ARG B 28 SER B 150 SER B 151 SITE 3 AC2 13 PRO B 152 ARG B 213 SER B 215 HOH B 527 SITE 4 AC2 13 HOH B 592 SITE 1 AC3 20 SER B 56 GLY B 58 GLY B 81 CYS B 82 SITE 2 AC3 20 GLY B 83 GLY B 86 TRP B 87 THR B 104 SITE 3 AC3 20 LYS B 105 HIS B 110 GLU B 111 VAL B 130 SITE 4 AC3 20 ASP B 131 VAL B 132 PHE B 133 ASP B 146 SITE 5 AC3 20 HOH B 524 HOH B 563 HOH B 564 HOH B 602 SITE 1 AC4 17 SER A 56 GLY A 58 GLY A 81 CYS A 82 SITE 2 AC4 17 GLY A 86 TRP A 87 THR A 104 LYS A 105 SITE 3 AC4 17 HIS A 110 VAL A 130 ASP A 131 VAL A 132 SITE 4 AC4 17 PHE A 133 ASP A 146 ILE A 147 HOH A 448 SITE 5 AC4 17 HOH A 658 CRYST1 79.423 80.280 84.814 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012591 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012456 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011791 0.00000